Dorsey Wright & Associates Ocular Therapeutix, Inc Transaction History

Dorsey Wright & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$15.82 - $22.11 $26,039 - $36,393	-1,646 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$7.91 - $22.95 $3,258 - $9,455	412 Added 33.39%	1,646 $34,000
Q3 2020 Oct 28, 2020	SELL	$7.36 - $9.87 $3,032 - $4,066	-412 Reduced 25.03%	1,234 $9,000
Q1 2020 Apr 20, 2020	BUY	$3.95 - $7.4 $6,501 - $12,180	1,646 New	1,646 $8,000

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.